The healthcare workforce is critically understaffed and under-resourced, particularly for patients with Alzheimer's and related diseases. New medications have highlighted these systemic issues, revealing the need for a more robust care model. Patients often face long waitlists and prolonged uncertainty, contrasting sharply with the swift responses seen in other medical fields.
